Clinical trials are an important way to improve treatment for people with cancer. While most are continuing during the COVID-19 pandemic, the period of time that clinical trials are available and recruiting may change quickly. If you would like to get involved in a clinical trial, speak to your treatment team or the health service where the clinical trial is being undertaken, to confirm it is open and appropriate for you. For cancer information and support, call Cancer Council's experienced cancer nurses on 13 11 20 Monday to Friday from 9am-5pm.

Latest Trials

Systemic therapy trial

TRIDENT-1 : A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability,...

This phase I/II trial is trying to determine the safety and tolerability of an oral drug, repotrectinib

Status : Recruiting

Systemic therapy trial

WU-KONG1 : A Phase I/II, Open-Label, Multicenter Study to Assess the Safety, Tolerability,...

This phase I/II trial is evaluating the effectiveness and safety of a new targeted therapy (DZD9008) to treat advanced recurrent Non-small Cell Lung Cancer with EGFR or HER2 mutations

Status : Recruiting

Systemic therapy trial

A Phase I, Open-Label, Dose-Escalation Study Of The Safety And Pharmacokinetics Of...

This phase I study is trying to understand how safe, tolerable and effective a new anti-cancer drug (BLYG8824A) is in people with colorectal cancer.

Status : Recruiting

Systemic therapy trial

BREAKWATER : AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF FIRST-LINE ENCORAFENIB PLUS...

This phase III trial is evaluating whether targeted therapy, alone or in combination with chemotherapy, is more effective than standard care in patients with metastatic colorectal (bowel) cancer

Status : Recruiting

Systemic therapy trial

DREAM3R : DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural...

This phase III trial is trying to understand whether adding a form of targeted therapy to standard chemotherapy will improve overall survival for patients with malignant pleural mesothelioma

Status : Recruiting

Treatment trial

An Open-label, Multi-center, Phase I Study of Oral IAG933 in Adult Patients With Advanced...

This phase I study is aiming to determine the best dose level and safety of a new cancer drug (IAG933) in people with advanced mesothelioma and other solid cancers

Status : Recruiting

Systemic therapy trial

FLAGSHP-1 : An Open-Label, Multi-Center Phase 1/1b Dose Escalation and Expansion Study of ERAS-601...

This phase I trial is evaluating how safe and effective a targeted cancer drug (ERAS-601) is alone, or when combined with another targeted therapy (Cetuximab) in people with advanced or metastatic solid cancers

Status : Recruiting

Systemic therapy trial

ARTEMIDE-01 : Phase I/II, Open-label, Dose Escalation and Dose Expansion Study to Evaluate Safety,...

This phase I/II study is evaluating how safe and effective a new cancer drug (AZD2936) is in people with advanced or metastatic non-small cell lung cancer

Status : Recruiting

Treatment trial

SEAMARK : A PHASE 2, RANDOMIZED, OPEN-LABEL STUDY OF ENCORAFENIB AND CETUXIMAB PLUS PEMBROLIZUMAB...

This phase II is evaluating the effective of combination therapy (encorafenib, cetuximab and pembrolizumab) compared to immunotherapy alone (pembrolizumab) in people with previously untreated metastatic bowel cancer

Status : Recruiting

Systemic therapy trial

A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY EVALUATING THE SAFETY, TOLERABILITY,...

This phase I trial is trying to understand how safe and tolerable a new targeted therapy drug (PF-07062119) is in people with selected advanced or metastatic gastrointestinal cancers

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.